Chase C. Leavitt

Insider Reports History

Location
Alameda, CA
Signature
/s/Chase C. Leavitt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chase C. Leavitt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. General Counsel/Secretary Common Stock 84,758 $42,048 $0.4961 03 Jan 2024 Direct
Oncternal Therapeutics, Inc. General Counsel/Secretary Stock Option 14,200 14 Feb 2024 Direct

Insider Reports Filed by Chase C. Leavitt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919124003412-leavitt-chase-c-2024-02-14 Oncternal Therapeutics, Inc. 14 Feb 2024 1 $0 4 General Counsel/Secretary 15 Feb 2024, 18:00
/report/000120919124000971-leavitt-chase-c-2024-01-03 Oncternal Therapeutics, Inc. 03 Jan 2024 1 -$5,873 4 General Counsel/Secretary 05 Jan 2024, 16:00
/report/000120919123052023-leavitt-chase-c-2023-10-02 Oncternal Therapeutics, Inc. 02 Oct 2023 9 $0 4 General Counsel/Secretary 04 Oct 2023, 17:01
/report/000120919123041318-leavitt-chase-c-2023-07-03 Oncternal Therapeutics, Inc. 03 Jul 2023 1 -$3,710 4 General Counsel/Secretary 05 Jul 2023, 18:59
/report/000120919123024264-leavitt-chase-c-2023-04-12 Oncternal Therapeutics, Inc. 12 Apr 2023 2 +$7,250 4 General Counsel/Secretary 14 Apr 2023, 06:00
/report/000120919123012401-leavitt-chase-c-2023-02-21 Oncternal Therapeutics, Inc. 21 Feb 2023 1 $0 4 General Counsel/Secretary 23 Feb 2023, 19:01
/report/000120919123002031-leavitt-chase-c-2023-01-03 Oncternal Therapeutics, Inc. 03 Jan 2023 1 -$6,213 4 General Counsel/Secretary 05 Jan 2023, 17:00
/report/000120919122043739-leavitt-chase-c-2022-07-28 Oncternal Therapeutics, Inc. 28 Jul 2022 2 $0 4 General Counsel/Secretary 01 Aug 2022, 18:22
/report/000120919122005558-leavitt-chase-c-2022-01-27 Oncternal Therapeutics, Inc. 27 Jan 2022 2 +$23,280 4 General Counsel/Secretary 31 Jan 2022, 15:00
/report/000120919122004583-leavitt-chase-c-2022-01-20 Oncternal Therapeutics, Inc. 20 Jan 2022 1 $0 4 General Counsel/Secretary 24 Jan 2022, 15:00
/report/000120919122001973-leavitt-chase-c-2022-01-03 Oncternal Therapeutics, Inc. 03 Jan 2022 1 $0 4 General Counsel/Secretary 05 Jan 2022, 18:00
/report/000120919121040701-leavitt-chase-c-2021-06-11 Oncternal Therapeutics, Inc. 11 Jun 2021 1 +$8,175 4 General Counsel/Secretary 15 Jun 2021, 18:00
/report/000120919121036320-leavitt-chase-c-2021-05-25 Oncternal Therapeutics, Inc. 25 May 2021 0 $0 3 General Counsel/Secretary 27 May 2021, 18:06